相似文献
1
Regulation of different inflammatory diseases by impacting the mevalonate pathway.
Immunology. 2009 May;127(1):18-25. doi: 10.1111/j.1365-2567.2008.03011.x.
2
Immune modulatory effects of statins.
Immunology. 2018 May;154(1):69-75. doi: 10.1111/imm.12902. Epub 2018 Feb 20.
3
The beneficial effects of statins in autoimmune disease therapy.
Drug News Perspect. 2007 Apr;20(3):165-9. doi: 10.1358/dnp.2007.20.3.1092097.
4
Statins: pros and cons.
Med Clin (Barc). 2018 May 23;150(10):398-402. doi: 10.1016/j.medcli.2017.11.030. Epub 2017 Dec 29.
5
Statins and autoimmune diseases.
Autoimmun Rev. 2005 Mar;4(3):123-9. doi: 10.1016/j.autrev.2004.08.037.
6
Mevalonate signaling, COPD and cancer: the statins and beyond.
J Investig Med. 2019 Apr;67(4):711-714. doi: 10.1136/jim-2018-000829. Epub 2019 Feb 20.
7
Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
Int Immunopharmacol. 2006 Dec 5;6(12):1833-46. doi: 10.1016/j.intimp.2006.08.006. Epub 2006 Sep 7.
8
Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
Curr Mol Pharmacol. 2017;10(1):6-12. doi: 10.2174/1874467209666160112125805.
9
Influence of statins on MHC class I expression.
Ann N Y Acad Sci. 2009 Sep;1173:746-51. doi: 10.1111/j.1749-6632.2009.04646.x.
10
Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors.
Cardiovasc Hematol Agents Med Chem. 2009 Oct;7(4):279-94. doi: 10.2174/187152509789541864.
引用本文的文献
1
Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.
Pharmacol Rep. 2025 Feb;77(1):43-71. doi: 10.1007/s43440-024-00678-2. Epub 2024 Dec 16.
2
Excessive endometrial PlGF- Rac1 signalling underlies endometrial cell stiffness linked to pre-eclampsia.
Commun Biol. 2024 May 4;7(1):530. doi: 10.1038/s42003-024-06220-7.
3
Lovastatin promotes the self-renewal of murine and primate spermatogonial stem cells.
Stem Cell Reports. 2023 Apr 11;18(4):969-984. doi: 10.1016/j.stemcr.2023.02.011.
4
Repurposing Cardio-Metabolic Drugs to Fight Covid19.
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):419-423. doi: 10.1007/s40292-021-00475-5. Epub 2021 Sep 15.
5
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
Immunopharmacol Immunotoxicol. 2021 Aug;43(4):395-409. doi: 10.1080/08923973.2021.1931302. Epub 2021 May 31.
6
Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis.
J Clin Med. 2021 Feb 17;10(4):807. doi: 10.3390/jcm10040807.
7
Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):714-732. doi: 10.1161/ATVBAHA.119.313832. Epub 2020 Jan 30.
8
On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells.
Immunol Res. 2019 Oct;67(4-5):310-324. doi: 10.1007/s12026-019-09089-5.
9
Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Curr Atheroscler Rep. 2018 Feb 8;20(2):9. doi: 10.1007/s11883-018-0708-z.
10
Immune modulatory effects of statins.
Immunology. 2018 May;154(1):69-75. doi: 10.1111/imm.12902. Epub 2018 Feb 20.
本文引用的文献
1
Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus.
Arthritis Rheum. 2008 Jul;58(7):2098-104. doi: 10.1002/art.23605.
2
Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow.
Atherosclerosis. 2008 Sep;200(1):69-79. doi: 10.1016/j.atherosclerosis.2007.12.018. Epub 2008 May 16.
3
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988.
4
Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
Cardiovasc Res. 2008 Jul 1;79(1):14-23. doi: 10.1093/cvr/cvn099. Epub 2008 Apr 22.
5
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928.
6
Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation.
Arch Pharm Res. 2008 Feb;31(2):195-204. doi: 10.1007/s12272-001-1141-2.
7
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation.
Blood. 2008 Apr 1;111(7):3901-2. doi: 10.1182/blood-2008-01-132050.
8
Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin.
J Cardiovasc Pharmacol. 2008 Mar;51(3):246-52. doi: 10.1097/FJC.0b013e3181624aed.
9
Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 week controlled trial.
Rheumatology (Oxford). 2008 Mar;47(3):381-2; author reply 382-3. doi: 10.1093/rheumatology/kem381. Epub 2008 Jan 28.
10
Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.
J Thromb Haemost. 2008 Apr;6(4):692-700. doi: 10.1111/j.1538-7836.2008.02913.x. Epub 2008 Jan 23.
Zotero 插件